ANTIBODY-DRUG CONJUGATES TARGETING uPARAP

16/74,961 | U.S. Patent Application

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Location ELECTRONIC
Filed Aug. 2, 2018
Examiner RUIXIANG LI
Class 424
Art Group 1646
Case Type Utility - 424/181100
Status Non Final Action Mailed
Parent PCT/DK2017/050024 -
Child PA 2016 70063
Child PA 2016 70834
Last Updated: 4 years, 9 months ago
Date # Transaction
6/5/2020

Event:

Office Action
Mail Non-Final Rejection
2/15/2019Email Notification
2/14/2019Application ready for PDX access by participating foreign offices
2/14/2019PG-Pub Issue Notification
1/24/2019Case Docketed to Examiner in GAU
1/18/2019Email Notification
1/18/2019Email Notification
1/18/2019Filing Receipt - Updated
1/18/2019Notice of DO/EO Acceptance Mailed
1/17/2019Transfer Inquiry to GAU
1/17/2019Application Is Now Complete
1/17/2019Application Dispatched from OIPE
1/17/2019FITF set to YES - revise initial setting
1/3/2019Additional Application Filing Fees
11/6/2018Electronic Review
11/6/2018Email Notification
11/6/2018Email Notification
11/6/2018371 Supplemental Fees Missing - Form M923
11/6/2018Filing Receipt
8/28/2018Information Disclosure Statement (IDS) Filed
8/9/2018Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27
8/6/2018CRF Is Good Technically / Entered into Database
8/3/2018Cleared by OIPE CSR
8/2/2018Request for Foreign Priority (Priority Papers May Be Included)
8/2/2018371 Completion Date
8/2/2018Patent Term Adjustment - Ready for Examination
8/2/2018Copy of the International Application
8/2/2018PTO/SB/69-Authorize EPO Access to Search Results
8/2/2018Applicants have given acceptable permission for participating foreign
8/2/2018CRF Disk Has Been Received by Preexam / Group / PCT
8/2/2018ENTITY STATUS SET TO UNDISCOUNTED (INITIAL DEFAULT SETTING OR STATUS CHANGE)
8/2/2018Initial Exam Team nn